Back to Search Start Over

Mycobacterium tuberculosis PptT Inhibitors Based on Heterocyclic Replacements of Amidinoureas.

Authors :
Ottavi S
Li K
Cacioppo JG
Perkowski AJ
Ramesh R
Gold BS
Ling Y
Roberts J
Singh A
Zhang D
Mosior J
Goullieux L
Roubert C
Bacqué E
Sacchettini JC
Nathan CF
Aubé J
Source :
ACS medicinal chemistry letters [ACS Med Chem Lett] 2023 Jun 26; Vol. 14 (7), pp. 970-976. Date of Electronic Publication: 2023 Jun 26 (Print Publication: 2023).
Publication Year :
2023

Abstract

4'-Phosphopantetheinyl transferase (PptT) is an essential enzyme for Mycobacterium tuberculosis ( Mtb ) survival and virulence and therefore an attractive target for a tuberculosis therapeutic. In this work, two modeling-informed approaches toward the isosteric replacement of the amidinourea moiety present in the previously reported PptT inhibitor AU 8918 are reported. Although a designed 3,5-diamino imidazole unexpectedly adopted an undesired tautomeric form and was inactive, replacement of the amidinourea moiety afforded a series of active PptT inhibitors containing 2,6-diaminopyridine scaffolds.<br />Competing Interests: The authors declare no competing financial interest.<br /> (© 2023 American Chemical Society.)

Details

Language :
English
ISSN :
1948-5875
Volume :
14
Issue :
7
Database :
MEDLINE
Journal :
ACS medicinal chemistry letters
Publication Type :
Academic Journal
Accession number :
37465309
Full Text :
https://doi.org/10.1021/acsmedchemlett.3c00162